Aeglea BioTherapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Aeglea BioTherapeutics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 88% to $2,329,000. Profit margin reached -3599%. Total operating expenses were $87,110,000.
Profit Margin
| 2014 | 0 | -10.34M | |
|---|---|---|---|
| 2015 | 6.08M | -11.29M | -185.62% |
| 2016 | 4.62M | -21.69M | -468.84% |
| 2017 | 5.20M | -27.23M | -523.27% |
| 2018 | 3.88M | -44.34M | -1140.64% |
| 2019 | 0 | -75.69M | |
| 2020 | 0 | -80.3M | |
| 2021 | 18.73M | -65.80M | -351.14% |
| 2022 | 2.32M | -83.81M | -3598.75% |
AGLE Income Statement (2014 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 2.32M | 18.73M | 0 | 0 | 3.88M | 5.20M | 4.62M | 6.08M | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 2.32M | 18.73M | 0 | 0 | 3.88M | 5.20M | 4.62M | 6.08M | 0 |
Operating exp. | |||||||||
Research and development | 58.57M | 57.06M | 59.63M | 64.6M | 36.71M | 22.81M | 18.14M | 11.45M | 6.83M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 87.11M | 84.38M | 81.48M | 80.33M | 49.35M | 32.88M | 26.53M | 17.4M | 8.90M |
Operating income | -84.78M | -65.64M | -81.48M | -80.33M | -45.46M | -27.67M | -21.90M | -11.31M | -8.90M |
Other income (expenses), net | 830K | -11K | 588K | 2.08M | -57K | -42K | -36K | 20K | -1.44M |
Income before tax | -83.95M | -65.66M | -80.89M | -78.25M | -44.34M | -27.23M | -21.69M | -11.29M | -10.34M |
Income tax expense | -136K | 141K | -593K | -2.56M | -57K | -731K | -244K | -22K | 1.44M |
Net income | -83.81M | -65.80M | -80.3M | -75.69M | -44.34M | -27.23M | -21.69M | -11.29M | -10.34M |
Earnings per share | |||||||||
Basic EPS | -24.86 | -25.02 | -37.61 | -2.37 | -53.25 | -45.01 | -55.4 | -24.71 | -37.93 |
Diluted EPS | -24.86 | -25.02 | -37.61 | -2.37 | -53.25 | -45.01 | -55.4 | -24.71 | -37.93 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |